Liver resection remains the main curative option for many patients with primary and secondary liver malignancies, including ...

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. PFE’s New Liver Cancer Trial: Early Signal to Watch The study, officially ...

Hepatocellular carcinoma (HCC) is the most common type of liver cancer. Most people who develop this cancer have chronic liver disease. Treatments typically include surgery, chemotherapy, ...

Finn RS, Ryoo B-Y, Hsu C-H, et al: Results from the MORPHEUS-liver study: Phase Ib/II randomized evaluation of tiragolumab (tira) in combination with atezolizumab (atezo) and bevacizumab (bev) in ...

Recurrence beyond Milan criteria predicts worse outcomes after hepatocellular carcinoma resection. Limited recurrence remains ...

Neuroendocrine liver cancer develops in cells that produce hormones in response to nerve signals. Most neuroendocrine liver cancers spread from other organs. Liver cancer accounts for more than ...